Cetera Investment Advisers Sells 4,301 Shares of The Ensign Group, Inc. $ENSG

Cetera Investment Advisers lessened its position in shares of The Ensign Group, Inc. (NASDAQ:ENSG) by 10.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,749 shares of the company’s stock after selling 4,301 shares during the quarter. Cetera Investment Advisers’ holdings in The Ensign Group were worth $7,606,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in ENSG. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of The Ensign Group by 9.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock worth $20,956,000 after acquiring an additional 14,590 shares in the last quarter. Geneos Wealth Management Inc. boosted its position in shares of The Ensign Group by 150.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after acquiring an additional 230 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of The Ensign Group by 65.9% in the second quarter. EverSource Wealth Advisors LLC now owns 536 shares of the company’s stock valued at $83,000 after purchasing an additional 213 shares in the last quarter. Amundi grew its holdings in shares of The Ensign Group by 480,216.7% in the second quarter. Amundi now owns 57,638 shares of the company’s stock valued at $8,583,000 after purchasing an additional 57,626 shares in the last quarter. Finally, Brown Advisory Inc. grew its holdings in shares of The Ensign Group by 26.1% in the second quarter. Brown Advisory Inc. now owns 2,037 shares of the company’s stock valued at $314,000 after purchasing an additional 421 shares in the last quarter. Institutional investors own 96.12% of the company’s stock.

The Ensign Group Price Performance

Shares of The Ensign Group stock opened at $178.16 on Friday. The stock has a market cap of $10.38 billion, a price-to-earnings ratio of 27.92, a price-to-earnings-growth ratio of 1.71 and a beta of 0.69. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.21. The stock has a 50 day moving average price of $165.81 and a 200-day moving average price of $183.96. The Ensign Group, Inc. has a one year low of $141.58 and a one year high of $218.00.

The Ensign Group (NASDAQ:ENSG) last released its earnings results on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.80 by $0.12. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%.The firm had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the previous year, the company posted $1.59 EPS. The company’s revenue for the quarter was up 16.7% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Equities analysts expect that The Ensign Group, Inc. will post 6.93 EPS for the current year.

The Ensign Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a yield of 0.1%. The ex-dividend date of this dividend was Tuesday, June 30th. The Ensign Group’s payout ratio is presently 4.08%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ENSG. Weiss Ratings downgraded shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, June 16th. Zacks Research lowered shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Truist Financial lifted their price objective on shares of The Ensign Group from $202.00 to $207.00 and gave the stock a “hold” rating in a research note on Thursday. Wall Street Zen downgraded shares of The Ensign Group from a “buy” rating to a “hold” rating in a report on Saturday, July 25th. Finally, Royal Bank Of Canada restated an “outperform” rating and set a $228.00 target price on shares of The Ensign Group in a research report on Tuesday. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $216.25.

Insiders Place Their Bets

In other news, Director Barry M. Smith sold 700 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total value of $114,996.00. Following the completion of the sale, the director owned 21,352 shares in the company, valued at approximately $3,507,706.56. This trade represents a 3.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of The Ensign Group stock in a transaction dated Monday, July 20th. The stock was sold at an average price of $171.06, for a total transaction of $67,055.52. Following the transaction, the director directly owned 9,503 shares of the company’s stock, valued at approximately $1,625,583.18. This represents a 3.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,792 shares of company stock worth $309,599 in the last quarter. Company insiders own 4.00% of the company’s stock.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.